Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/23/2010 | EP1613348B1 Methods for modulating angiogenesis with apelin compositions |
06/23/2010 | EP1608400B1 Elevation of adenosine level by cytokine-induced expression of cd73 |
06/23/2010 | EP1441747B1 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
06/23/2010 | EP1400550B1 Branched polyalkylene glycols |
06/23/2010 | EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
06/23/2010 | CN1898257B Methods for synthesis of encoded libraries |
06/23/2010 | CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
06/23/2010 | CN1871351B Novel fungal proteins and nucleic acids encoding same |
06/23/2010 | CN1871256B Muteins of tear lipocalin |
06/23/2010 | CN1837237B Recombinant human interleukin1 receptor antagon (rhIL-1ra) with low pyrogen and its high efficiency preparation process |
06/23/2010 | CN1809378B Methods for inhibiting viral replication in vivo |
06/23/2010 | CN1777443B Methods of diagnosing and treating pre-eclampsia or eclampsia |
06/23/2010 | CN1697648B Azithromycin dosage forms with reduced side effects |
06/23/2010 | CN1620304B Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
06/23/2010 | CN1468108B Bone health compositions derived from milk |
06/23/2010 | CN1446100B Method for treating movement disorder |
06/23/2010 | CN101754974A Macrocyclic compounds as antiviral agents |
06/23/2010 | CN101754769A The use of type-B lantibiotic-based compounds having antimicrobial activity |
06/23/2010 | CN101754768A Survivin peptides as cancer vaccines |
06/23/2010 | CN101754747A Methods and compositions for delivery of medicaments to the lungs |
06/23/2010 | CN101754688A Glycated milk and uses thereof |
06/23/2010 | CN101748180A Functional peanut small molecule mixed polypeptide, preparation method and application thereof |
06/23/2010 | CN101748179A Preparation method of feather protein peptide |
06/23/2010 | CN101748110A Desmoteplase alpha 1 mutant |
06/23/2010 | CN101747440A TNFR-Fc fusion protein and usage thereof |
06/23/2010 | CN101747437A Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein |
06/23/2010 | CN101747430A Two peptides with oxidation resistant function - Fe-Alpha29 peptide-porphyrin iron and Beta13 peptide-porphyrin iron |
06/23/2010 | CN101747424A Polypeptide for male immunocontraception |
06/23/2010 | CN101747423A Centipede anti-tumor active protein |
06/23/2010 | CN101747414A Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
06/23/2010 | CN101747413A Envelope glycoprotein penetrating oligopeptide or modifier/ derivative thereof with blood platelet apoptosis activity inhibiting function and application |
06/23/2010 | CN101747411A Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof |
06/23/2010 | CN101747410A Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof |
06/23/2010 | CN101747408A Technology for producing polypeptide-Fe through taking animal blood as raw material |
06/23/2010 | CN101745118A Cell cytokine for treatment of Alzheimer |
06/23/2010 | CN101745114A Method for preparing glucose-sensitive insulin controlled-release biological material |
06/23/2010 | CN101745103A Normal-temperature preserved albumin preparation |
06/23/2010 | CN101745102A Composition of 5-aminolevulinic acid and derivative thereof as well as application thereof |
06/23/2010 | CN101745101A Skin external-use composition for promoting wound healing |
06/23/2010 | CN101745100A Buccal insulin dropping pill and preparation method thereof |
06/23/2010 | CN101745099A High-voltage electrostatic bur bract electric field foot patch for diabetes |
06/23/2010 | CN101745098A Application of nerve polypeptide PACAP38 in the preparation of eye disease curing, injury repair or reproduction drugs |
06/23/2010 | CN101745097A Alpha-conotoxins from Hainan province for specific blockage of acetylcholine receptor and application thereof |
06/23/2010 | CN101745096A Combined medicament of brain protein hydrolysate |
06/23/2010 | CN101745095A Composition of reduced glutathione and sodium carbonate or sodium bicarbonate |
06/23/2010 | CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant |
06/23/2010 | CN101744845A Chlorella extractive composition and preparation method thereof |
06/23/2010 | CN101744768A Protein or nucleic acid drug liposome preparation and preparation method thereof based on tetraether lipid |
06/23/2010 | CN101224298B Propofol compounds |
06/23/2010 | CN101003569B Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application |
06/22/2010 | US7741532 Diacylglycerol acyl transferase proteins |
06/22/2010 | US7741468 protein hLRTM4 and the polynucleotide which encodes it; used to treat liver injury, hepatocellular carcinoma |
06/22/2010 | US7741453 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability |
06/22/2010 | US7741451 Antibodies that specifically bind hedgehog-derived polypeptides |
06/22/2010 | US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients |
06/22/2010 | US7741440 Apoptin-associating protein |
06/22/2010 | US7741439 Isolated stra6 polypeptides |
06/22/2010 | US7741437 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
06/22/2010 | US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue |
06/22/2010 | US7741435 Substance P-saporin (SP-SAP) conjugates and methods of use thereof |
06/22/2010 | US7741434 High-affinity antagonists of ELR-CXC chemokines |
06/22/2010 | US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
06/22/2010 | US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride |
06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
06/22/2010 | US7741310 A polynucleotide encodes an arginase, a nerve growth factors for treating nervous system disorders, neurodegenerative diseases |
06/22/2010 | US7741308 DBAIT and uses thereof |
06/22/2010 | US7741307 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
06/22/2010 | US7741305 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease |
06/22/2010 | US7741303 Stimulation of cellular regeneration and differentiation in the inner ear |
06/22/2010 | US7741302 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids |
06/22/2010 | US7741301 Transposase and method of gene modification |
06/22/2010 | US7741300 Methods of using nucleic acid vector-lipid complexes |
06/22/2010 | US7741292 Method of inhibiting the emigration of cells from the intravascular compartment into tissues |
06/22/2010 | US7741290 protein kinase C inhibitors (PKC); heart transplants |
06/22/2010 | US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
06/22/2010 | US7741288 serine/threonine phosphatases (PP1); immobilization, screening |
06/22/2010 | US7741287 Peptides for the treatment of herpes virus infections |
06/22/2010 | US7741286 kringle peptides; peptidase stabilized |
06/22/2010 | US7741285 APO-2 ligand/trail formulations |
06/22/2010 | US7741284 BMP10 propeptides and related methods |
06/22/2010 | US7741283 transforming growth factor and insulin like growth factor binding protein 3 as ligands that engage low density lipoprotein receptor-related protein |
06/22/2010 | US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
06/22/2010 | US7741281 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
06/22/2010 | US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
06/22/2010 | US7741279 Modified pro-alpha chain of at least part of a secretory leukocyte protease inhibitor that is placed N-terminal to a triple helical forming domain of the pro-alpha chain; procollagen molecule; collagen matrix; treating chronic wounds and fibrotic disorders |
06/22/2010 | US7741278 Modified proteins, designer toxins, and methods of making thereof |
06/22/2010 | US7741277 reacting disorazole compound with a linkerto yield a mono- and/or bisfunctionalized disorazole-linker moiety, coupling mono- and/or bisfunctionalized disorazole-linker moiety with cell-binding molecules(peptide, protein, protein/peptide hormones, receptor ligand, blood plasma protein) to from conjugate |
06/22/2010 | US7741276 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
06/22/2010 | US7741275 Short interfering RNA sequences specific for cathelicidin (cap18) gene for use in treatment and prevention of cell proliferative disorders |
06/22/2010 | US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
06/22/2010 | US7741273 Drug dosage device designed for delivery of antiinflammatory or anabolic compounds to intervertebral discs or articulating joints, and for insertion of drug depots into discs or joint capsules with minimal tissue disruption and minimal interference with normal joint motion |
06/22/2010 | US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders |
06/22/2010 | US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM) |
06/22/2010 | US7741269 Exendins and exendin agonists for weight reduction and obesity |
06/22/2010 | US7741268 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent |
06/22/2010 | US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
06/22/2010 | US7741112 nucleic acid comprising a sequence encoding a mitochondrial localization signal from subunit VIII of human cytochrome oxidase operably linked to a sequence encoding a viral receptor |
06/22/2010 | US7741111 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis |
06/22/2010 | US7741090 Glucose dehydrogenase and process for producing the dehydrogenase |
06/22/2010 | US7741085 Compound WS727713 |